Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Imaging and Biology|November 17, 2020
Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in RatsDavid Rey-Bretal, Alexis Moscoso, Noemí Gómez-Lado, et al.
Neuroimage|May 24, 2020
White matter hyperintensities are associated with subthreshold amyloid accumulationAlexis Moscoso, David Rey-Bretal, Jesús Silva-Rodríguez, et al.
Healthcare (Basel, Switzerland)|January 28, 2026
Enhancing Quality of Life in Ostomized Patients Through Smart-Glasses-Supported Health Education: A Pre-Post StudyEmilio Rubén Pego Pérez, Tomás Mendoza Caamaño, David Rey-Bretal, et al.
Molecular Pharmaceutics|December 1, 2025
Longitudinal [<sup>18</sup>F]FMISO PET Evaluation of Hypoxic Tissue in a Rat Model of Hindlimb IschemiaNoemí Gómez-Lado, David Rey-Bretal, Manuel Piñeiro-Fiel, et al.
Neuroimage|September 28, 2024
Quantitative brain [<sup>18</sup>F]FDG PET beyond normal blood glucose levelsDavid Rey-Bretal, Lara García-Varela, Noemí Gómez-Lado, et al.
European Radiology|November 28, 2020
Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
International Journal of Pharmaceutics|October 8, 2022
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat modelXurxo García-Otero, Cristina Mondelo-García, Enrique Bandín-Vilar, et al.
International Journal of Pharmaceutics|October 9, 2019
Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal modelIria Seoane-Viaño, Noemí Gómez-Lado, Héctor Lázare-Iglesias, et al.
International Journal of Pharmaceutics|January 15, 2024
Biodistribution and pharmacokinetics of [<sup>89</sup>Zr]-anti-VEGF mAbs using PET in glioblastoma rat modelsLara García-Varela, Jessica Codesido, Alberto Perez-Pedrosa, et al.
Pharmaceutics|April 3, 2021
Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 InfectionAna Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, et al.
Pageof 1